These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9050920

  • 1. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
    Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo LO, Larsson C.
    Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T, Twigg S, Delbridge L, Wong FK, Farnebo F, Richardson AL, Nelson A, Zedenius J, Philips J, Larsson C, Teh BT, Robinson B.
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
    Välimäki S, Forsberg L, Farnebo LO, Larsson C.
    Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
    [Abstract] [Full Text] [Related]

  • 5. Molecular genetics of primary and secondary hyperparathyroidism.
    Dotzenrath C, Goretzki PE, Farnebo F, Teh BT, Weber G, Röher HD, Larsson C.
    Exp Clin Endocrinol Diabetes; 1996 Oct; 104 Suppl 4():105-7. PubMed ID: 8981014
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Putative parathyroid tumor suppressor on 1p: independent molecular mechanisms of tumorigenesis from 11q allelic loss.
    Imanishi Y, Tahara H.
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S165-7. PubMed ID: 11576946
    [Abstract] [Full Text] [Related]

  • 10. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H.
    Int Surg; 1996 Nov; 81(1):71-6. PubMed ID: 8803711
    [Abstract] [Full Text] [Related]

  • 15. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N, Alvarez V, Diaz-Cadorniga F, Aller J, Villazon F, Garcia I, Herrero A, Coto E.
    Anticancer Res; 1998 Nov; 18(4A):2685-9. PubMed ID: 9703929
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ.
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.